These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 2748943)

  • 1. X-ray crystallography and sickle cell disease drug discovery-a tribute to Donald Abraham.
    Donkor AK; Pagare PP; Mughram MHA; Safo MK
    Front Mol Biosci; 2023; 10():1136970. PubMed ID: 37293554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.
    Chaplin DJ; Trotter MJ; Skov KA; Horsman MR
    Br J Cancer; 1990 Oct; 62(4):561-6. PubMed ID: 2145963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modification of hemoglobin affinity for oxygen and tumor radiosensitivity by antilipidemic drugs.
    Hirst DG; Wood PJ; Schwartz HC
    Radiat Res; 1987 Oct; 112(1):164-72. PubMed ID: 3477829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorophenoxy acetic acid derivatives as hemoglobin modifiers and tumor radiosensitizers.
    Hirst DG; Wood PJ
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1183-6. PubMed ID: 2715068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour radiosensitization by clofibrate and its analogs: possible mechanisms.
    Hirst DG
    Adv Exp Med Biol; 1990; 277():917-25. PubMed ID: 2151413
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered radiosensitivity in a mouse carcinoma after administration of clofibrate and bezafibrate.
    Hirst DG; Wood PJ
    Radiother Oncol; 1989 May; 15(1):55-61. PubMed ID: 2748943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ tumour radiosensitization induced by clofibrate administration: single dose and fractionated studies.
    Calais G; Hirst DG
    Radiother Oncol; 1991 Oct; 22(2):99-103. PubMed ID: 1957008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrates: mechanism of action, effect on levels of lipids and lipoproteins, risk of coronary events. Part 1. Clofibrate, gemfibrosil, besafibrate].
    Dobordzhginidze LM; Gratsianskiĭ NA
    Kardiologiia; 2004; 44(2):96-103. PubMed ID: 15125434
    [No Abstract]   [Full Text] [Related]  

  • 10. Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia.
    Monk JP; Todd PA
    Drugs; 1987 Jun; 33(6):539-76. PubMed ID: 3301301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.
    Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A
    Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.